On Jan. 11, 2019, AstraZeneca announced it had closed plants in Colorado and layed off 210 workers AstraZeneca purchased the former Synergen LakeCentre biologics bulk manufacturing facility in Boulder, Colorado from Amgen in 2015 for $14.6 million and $64.5 million for Longmont in 2016.